Class of 2014 Abstract / Specific Aims: To compare trends in user demographics, clinical effects, and clinical outcomes associated with the use of synthetic cannabinoids and cathinones before and after signing into law the Synthetic Drug Abuse Prevention Act of 2012 on July 9, 2012. Methods: Reports generated by the National Poison and Drug Information Center’s Toxic Exposure Surveillance System were used to isolate calls regarding patients who reportedly used either synthetic cannabinoids or synthetic cathinones from July 2011 to March 2013. Clinical effects, clinical outcomes, and demographic information of patients associated with these calls from July 9, 2011 to July 8, 2012, were compared to that of patients associated with calls from July 9, 2012 to July 8, 2013. Main Results: Pending Conclusion: Pending

The legalization of medical marijuana has been a complicated and confusing process. The drug is used for medical purposes yet is only semi-legal and not approved by the federal government. This piece will observe the legal medical history of this drug in the United States. It will analyze the growth of the medical marijuana movement up to the present with a special emphasis to the importance of federal, state and local supremacy. It will observe important court cases that have been decisive in defining the reach of federal power under the Commerce Clause and the 1970 Controlled Substance Act. This analysis will look at the current legal standing of medical marijuana as well as the legal hurdles to achieve full legal status and medical recognition from state federal and local levels of government. A special focus will be given to the state of California because it has the largest medical marijuana market and has taken center stage in the movement to legalize marijuana as a medicine. This paper will also cover the growth of the state condoned medical marijuana black market and the complications that arise from taxing, and licensing semi-legal businesses. This paper will assess the monetary and personal costs of this movement and the political elements of resisting the medical development and scientific understanding of this drug. It will seek to suggest a solution to the current impasse and explain why medical marijuana in this instance has been bad medicine and dangerous policy.